| DRAVPe02102 |
GLRC-7 |
CRLGRLLRRLGRC |
HIV-1IIIB |
Not Avaialbe |
| DRAVPe02103 |
GLRC-5 |
GLRCRLGRLLRRLGRC |
HIV-1IIIB |
Not Avaialbe |
| DRAVPe02104 |
GLRC_4 |
GCRRLCGRLGRRLCRLLCR |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02105 |
GLRC-3 |
GLRRLCGRLGRRLCRLLLR |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02106 |
GLRC-2 |
GLRCRLGRLLRRLGRCLLR |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02107 |
GLRC-1 |
GCRRLLGRLLRRLGRLLCR |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02108 |
SB2 |
GSRRPVPIIYCNRRTGRCQRI |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02109 |
SB1 |
GSKKPVPIIYCNRRTGKCQRI |
HIV-1IIIB, HSV-2MS |
Not Avaialbe |
| DRAVPe02112 |
Anti-NN+B14:B21 |
GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC |
HIV-1 |
16140737 |
| DRAVPe02114 |
Esculentin-2P |
GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC |
HIV-1 |
16140737 |
| DRAVPe02117 |
Ginkbilobin |
ANTAFVSSAHNTQKIPAGAPFNRNLRAMLADLRQNAAFAG |
HIV |
11118300 |
| DRAVPe02118 |
Gramicidin A |
VGALAVVVWLWLWLW |
HIV,HSV |
9672588 |
| DRAVPe02121 |
Human histatin 5 |
DSHAKRHHGYKRKFHEKHHSHRGY |
HIV |
16940535 |
| DRAVPe02124 |
Human beta
defensin 2 |
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP |
HIV-1 |
16672548 |
| DRAVPe02125 |
Human beta
defensin 3 |
GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK |
HIV-1 |
16672548 |
| DRAVPe02126 |
Mirabamide G |
XYXTAGXAXLXPXQXKXVXGX |
HIV-1 |
21280591 |
| DRAVPe02127 |
Mirabamide H |
XYXTAGXAXLXPXQXKXVXG |
HIV-1 |
21280591 |
| DRAVPe02128 |
Stellettapeptin A |
XAXYXQLGXATXQXKXQXNH |
HIV-1 |
26139946 |
| DRAVPe02129 |
Stellettapeptin B |
XAXYXTLGGXATTXQXKXH |
HIV-1 |
26139946 |
| DRAVPe02130 |
Mollamide E |
XFPSLTCLSTXC |
HIV-1 |
22845329 |
| DRAVPe02131 |
Mollamide F |
XFPPVIXC |
HIV-1 |
22845329 |
| DRAVPe02133 |
Malformin C |
XCXCVXLL |
HIV-1 |
26711143 |
| DRAVPe02135 |
Divamide A |
ECASTCSFGIVTIVCDGTTK |
HIV-1 |
29291350 |
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.